A phase I study of the combination of sorafenib with temozolomide and radiation therapy for the treatment of primary and recurrent high-grade gliomas
about
Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma.The challenges and the promise of molecular targeted therapy in malignant gliomas.Inefficiencies and Patient Burdens in the Development of the Targeted Cancer Drug Sorafenib: A Systematic ReviewSorafenib selectively depletes human glioblastoma tumor-initiating cells from primary cultures.Combining molecular targeted agents with radiation therapy for malignant gliomasRe-irradiation alternatives for recurrent high-grade glioma.Refined brain tumor diagnostics and stratified therapies: the requirement for a multidisciplinary approach.New molecules and old drugs as emerging approaches to selectively target human glioblastoma cancer stem cells.Molecular targets in glioblastoma.Radiation recall dermatitis induced by sorafenib : A case study and review of the literature.Experiment research on inhibition of glioma with sTRAIL in vitro.Sorafenib inhibits cell growth but fails to enhance radio- and chemosensitivity of glioblastoma cell lines.Anti-angiogenic therapy in high-grade glioma (treatment and toxicity).Human mesenchymal stromal cells as cellular drug-delivery vectors for glioblastoma therapy: a good deal?Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma.From imaging to biology of glioblastoma: new clinical oncology perspectives to the problem of local recurrence.Pattern of relapse of glioblastoma multiforme treated with radical radio-chemotherapy: Could a margin reduction be proposed?Multiparametric MRI as an early biomarker of individual therapy effects during concomitant treatment of brain tumours.The diagnostic role and clinical relevance of determination of BRAF status in brain tumors.Casein Kinase 1 Epsilon Regulates Glioblastoma Cell Survival
P2860
Q33414998-2EDE6FC7-3B69-4E07-97EA-A0B82E08FF3BQ35214534-5FBFDC56-C91D-4C14-885D-85BA631FBB9DQ36270115-27E655D8-BB2C-4314-86B1-10966FF64850Q36654402-27B64DDB-B363-4C13-A9F5-644FA4BB24C2Q37099594-F68EB7E3-D92E-4AA9-A920-FED3112E3E71Q37289558-C150D667-AF7C-4A78-9B61-CB414A2E6329Q38108186-4D261525-8765-4931-A4B0-A27326DA2ADFQ38187997-493F5BCF-3530-4FA8-AFF3-BD026A9744CEQ38465854-B0EAF310-4C35-4CE4-A279-5B0DD789C1BFQ38747046-48C2BB58-118D-4D37-9E01-FF5C05E5BB66Q39071318-CF913880-525C-41DC-9037-CEB0160F52BCQ39472878-A29E2605-F05B-49C6-B30A-AF5E6CF8852AQ40705444-BDE81674-7AD2-4272-B305-3AC6B250A218Q42368133-55AFCDCE-BC70-4C42-A067-AD60A9784D55Q46004791-184B1A61-3EA2-45C2-A090-B600EFA142BEQ47863423-86CF8CAE-6682-42B5-BA7D-6370F55EB373Q52143325-03691115-D0B2-4B03-B332-3DD3C91E0A00Q53829611-DD035B20-7E84-4B2B-BD8E-97C3D6FFDFA5Q55461604-E7C0414F-7655-441F-A4CF-8BD76E58EE72Q58751776-EC9854B1-51E4-488B-8CCC-142622EC55CD
P2860
A phase I study of the combination of sorafenib with temozolomide and radiation therapy for the treatment of primary and recurrent high-grade gliomas
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A phase I study of the combina ...... d recurrent high-grade gliomas
@ast
A phase I study of the combina ...... d recurrent high-grade gliomas
@en
type
label
A phase I study of the combina ...... d recurrent high-grade gliomas
@ast
A phase I study of the combina ...... d recurrent high-grade gliomas
@en
prefLabel
A phase I study of the combina ...... d recurrent high-grade gliomas
@ast
A phase I study of the combina ...... d recurrent high-grade gliomas
@en
P2093
P2860
P50
P1476
A phase I study of the combina ...... d recurrent high-grade gliomas
@en
P2093
David P Friedman
David W Andrews
Erin Dougherty
Kevin Camphausen
Michael R Green
Michelle Marinucchi
Mitchell Kamrava
Terry Hyslop
Yaacov R Lawrence
P2860
P304
P356
10.1016/J.IJROBP.2012.04.017
P407
P577
2012-06-09T00:00:00Z